Kestra Investment Management LLC increased its position in shares of Chemed Corporation (NYSE:CHE – Free Report) by 64.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 3,007 shares of the company’s stock after buying an additional 1,181 shares during the quarter. Kestra Investment Management LLC’s holdings in Chemed were worth $1,287,000 at the end of the most recent quarter.
Other institutional investors have also added to or reduced their stakes in the company. Alps Advisors Inc. boosted its holdings in Chemed by 32.4% during the third quarter. Alps Advisors Inc. now owns 44,295 shares of the company’s stock valued at $19,833,000 after purchasing an additional 10,845 shares in the last quarter. Van Berkom & Associates Inc. boosted its holdings in Chemed by 33.0% during the third quarter. Van Berkom & Associates Inc. now owns 170,813 shares of the company’s stock valued at $76,480,000 after purchasing an additional 42,390 shares in the last quarter. SG Americas Securities LLC boosted its holdings in Chemed by 773.5% during the fourth quarter. SG Americas Securities LLC now owns 26,466 shares of the company’s stock valued at $11,324,000 after purchasing an additional 23,436 shares in the last quarter. Envestnet Asset Management Inc. boosted its holdings in Chemed by 6.5% during the third quarter. Envestnet Asset Management Inc. now owns 80,080 shares of the company’s stock valued at $35,855,000 after purchasing an additional 4,865 shares in the last quarter. Finally, Intech Investment Management LLC acquired a new stake in Chemed during the third quarter valued at approximately $1,429,000. 95.85% of the stock is owned by institutional investors and hedge funds.
Insider Activity
In other news, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction that occurred on Friday, May 1st. The shares were sold at an average price of $421.13, for a total value of $842,260.00. Following the completion of the transaction, the chief executive officer owned 90,219 shares in the company, valued at approximately $37,993,927.47. The trade was a 2.17% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Company insiders own 3.33% of the company’s stock.
Chemed Stock Performance
Chemed (NYSE:CHE – Get Free Report) last posted its earnings results on Thursday, April 23rd. The company reported $5.65 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.30 by $0.35. Chemed had a net margin of 10.23% and a return on equity of 27.18%. The company had revenue of $657.51 million during the quarter, compared to analysts’ expectations of $659.22 million. During the same quarter in the previous year, the company posted $5.63 earnings per share. Chemed’s quarterly revenue was up 1.6% compared to the same quarter last year. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. As a group, sell-side analysts anticipate that Chemed Corporation will post 22.3 EPS for the current fiscal year.
Chemed Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 16th. Stockholders of record on Thursday, May 28th will be paid a $0.60 dividend. The ex-dividend date is Thursday, May 28th. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.5%. Chemed’s payout ratio is 13.08%.
Analysts Set New Price Targets
A number of equities research analysts have weighed in on CHE shares. Oppenheimer decreased their price objective on Chemed from $580.00 to $500.00 and set an “outperform” rating on the stock in a report on Friday, February 27th. Wall Street Zen downgraded Chemed from a “buy” rating to a “hold” rating in a report on Saturday. Weiss Ratings raised Chemed from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, April 29th. Zacks Research raised Chemed from a “strong sell” rating to a “hold” rating in a report on Monday, April 27th. Finally, Royal Bank Of Canada lifted their price objective on Chemed from $422.00 to $436.00 and gave the company a “sector perform” rating in a report on Monday, April 27th. Two analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $501.50.
Get Our Latest Stock Report on CHE
Chemed Profile
Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.
The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.
Read More
- Five stocks we like better than Chemed
- Banks Are Buying Back Stock Hand Over Fist, Including These 3 Names
- 2 Aluminum Stocks Poised for Big Tariff-Related Gains
- AutoZone’s Pullback Sets Up a Long-Term Buying Opportunity
- AST SpaceMobile’s June Launch Plan Puts Its 2026 Satellite Goal Back in Focus
Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Corporation (NYSE:CHE – Free Report).
Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.
-EGX.png){kind=small}
